Basic Information

Common name
B-hPD-L1 EL4
Catalog number
310700
Aliases
CD274, PDCD1L1
Disease
Lymphoma
Organism
Mouse
Strain
C57BL/6N
Tissue types
Lymphoma
Tissue
T lymphocyte
Application
B-hPD-L1 EL4 cells have the capability to establish tumors in vivo and can be used for efficacy studies.
NCBI Gene ID

Description

The mouse Pdl1 gene was replaced by human PD-L1 coding sequence in B-hPD-L1 EL4 cells. Human PD-L1 is highly expressed on the surface of B-hPD-L1 EL4 cells.

Targeting strategy

Gene targeting strategy for B-hPD-L1 EL4 cells. The exogenous promoter and human PD-L1 coding sequence was inserted to replace part of murine exon 3. The insertion disrupts the endogenous murine Pdl1 gene, resulting in a non-functional transcript.

Protein expression analysis

PD-L1 expression analysis in B-hPD-L1 EL4 cells by flow cytometry. Single cell suspensions from wild-type EL4 and B-hPD-L1 EL4 cultures were stained with species-specific anti-PD-L1 antibody. Human PD-L1 was detected on the surface of B-hPD-L1 EL4 cells but not wild-type EL4 cells. The 6-G08 clone of B-hPD-L1 EL4 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes

Subcutaneous homograft tumor growth of B-hPD-L1 EL4 cells. B-hPD-L1 EL4 cells (2×105) and wild-type EL4 cells (2×105) were subcutaneously implanted into C57BL/6 mice (female, 7-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hPD-L1 EL4 cells were able to establish tumors in vivo and can be used for efficacy studies.

Animals with tumor volume over 3000mm3 in the control group were euthanized.

Back to top